An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

Stopped Parent, pivotal study (OC5-DB-02) did not meet primary endpoint. No safety concerns for early termination.

Conditions

• Hyperoxaluria, Primary

Interventions

• BIOLOGICAL: Oxabact OC5 - Oxalobacter formigenes Strain HC-1

Sponsor

OxThera